Pathologic Complete Response in the I-SPY 2 Trial

This week, we’ll start with a follow-up analysis of pathologic complete response in patients participating in the I-SPY 2 trial. Then, we’ll move on to a study that sought to answer whether a longer time from diagnosis to surgical treatment lowered overall survival in women with early-stage breast cancer. Last, we’ll hear about how the COVID-19 pandemic is worsening disparities in cancer care among racial and ethnic minorities and the medically underserved.

---